Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Eliquis Lawsuits Begin to Move Forward in Federal Multidistrict Litigation April 3, 2017 Austin Kirk Add Your Comments While tens of thousands of lawsuits have proceeded through the federal court system in recent years involving individuals who suffered uncontrollable bleeding on Xarelto and Pradaxa, a growing number of Eliquis lawsuits are now moving forward over similar problems linked to this third member of the same new class of anticoagulants. Eliquis, Xarelto and Pradaxa are all part of a new crop of blood thinners introduced in recent years, which have been aggressively marketed as replacements for Coumadin (warfarin) for prevention of blood clots. However, unlike warfarin, these novel oral anticoagulants were introduced without a proven antidote available to reverse the blood thinning effects of the drugs, resulting in a large number of reports involving bleed problems with Eliquis, Xarelto and Pradaxa, often resulting in hospitalization or death. After Pradaxa was the first member of this class introduced in October 2010, it quickly became the subject of several thousand lawsuits filed in courts nationwide, each involving allegations that the drug maker failed to adequately warn about the bleeding risk or lack of a Pradaxa reversal agent, which often left doctors helpless to stop bleeds that developed during use. Following several years of litigation, the manufacturer of that drug agreed to pay $650 million in Pradaxa settlements to resolve about 4,000 cases in 2014. Learn More About Eliquis Lawsuit Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Eliquis Lawsuit Learn More SEE IF YOU QUALIFY FOR COMPENSATION Xarelto was the second member of this class to hit the market in the U.S., and quickly grew to become the top selling novel oral anticoagulant after it was introduced in 2011. However, there are now more than 15,000 Xarelto lawsuits pending nationwide, each involving similar allegations that users suffered severe and often fatal bleeding complications. Following completion of generic discovery, a small group of Xarelto bellwether cases have been prepared for early trial dates, which are currently scheduled to begin in April. While the outcome of these Xarelto trials are not binding on other claims, they are designed to help the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation. While concerns over the safety of Xarelto and Pradaxa gained widespread attention, Eliquis has quietly became the most widely used member of this new class of drugs, and there is now rapidly growing litigation over that drug maker’s failure to warn about the side effects of Eliquis. In February, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for all Eliquis cases brought throughout the federal court system, centralizing the lawsuits before U.S. District Judge Denise L. Cote in the Southern District of New York for pretrial proceedings. Following an initial conference last month, Judge Cote issued a scheduling order (PDF), which outlines the path for moving the Eliquis litigation forward. By the end of this week, proposals will be submitted regarding the establishment of a Plaintiffs’ Steering Committee, which will include a group of Eliquis lawyers who will take certain actions during discovery and pretrial proceedings that benefit all individuals who are pursuing a case. Judge Cote has also directed the parties to submit a proposed case management order regarding the initial exchange of plaintiff fact sheets by April 14, as well as a proposed coordination order for state and federal Eliquis litigation by April 28. Following an initial exchange of interrogatories and document requests next month, the parties will submit a proposed discovery scheduled to the Court by June 2, 2017, which will likely outline the process for exchange information relevant to all cases over the remainder of this year. As part of the coordinated pretrial proceedings, it is likely that Judge Cote will establish a bellwether process in the future, which may involve a small group of Eliquis cases that will be prepared for early trial dates. However, the first case is unlikely to go before a jury until late 2018, unless Eliquis settlements are reached to resolve large numbers of claims prior to that time. Tags: Bleeding, Blood Thinners, Bristol Myers Squibb, Eliquis, Pfizer, Pradaxa, Xarelto More Eliquis Lawsuit Stories Eliquis More Effective At Preventing Recurring Blood Clots, Embolism, Than Xarelto: Study December 22, 2021 Eliquis Useful In Preventing Blood Clots, But Side Effects Include Major Bleeding Risks: Study December 26, 2018 FDA Approves AndexXa as Reversal Agent For Xarelto, Eliquis May 7, 2018 1 Comments FRED April 15, 2017 Been taking Eliquis for 2 years and now if I even get a scratch I bleed . My skin is all dark blackisk color with bruishes and looks like blood under the skin. Have to be very careful shaving. Now I have uncontrolled shaking in hands and arms. Was told it was a side affect of Eliquis and need to live with it because I need a blood thinner. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025) Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 5 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025)
Eliquis More Effective At Preventing Recurring Blood Clots, Embolism, Than Xarelto: Study December 22, 2021
Eliquis Useful In Preventing Blood Clots, But Side Effects Include Major Bleeding Risks: Study December 26, 2018
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 5 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025)